• VENTANA® MET (SP44) RxDx IHC Assay for non-squamous, non-small cell lung cancer (NSQ-NSCLC)
  • Myelodysplastic Syndrome (MDS), Flow Cytometry, Bone Marrow
  • HER2/neu (ERBB2), IHC, Semi-Quantitative, Other Tissue
  • Avantect Ovarian Cancer Test
  • Neuron Specific Enolase (NSE), CSF
  • Secobarbital, Serum
  • Apolipoprotein B, Serum
  • PLOD1 Gene Mutation Analysis
  • Lymphocytic Choriomeningitis (LCM) Virus Antibody, IgG
  • DNA Methylation Gene Panel for Barrett's Esophagus (EndoSign®)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /MYOZ2 (Calsarcin-1) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

MYOZ2 (Calsarcin-1) Gene Mutation Analysis
Medical Test

Reference Ranges
Access to MYOZ2 (Calsarcin-1) Gene Mutation Analysis is restricted.
Loading...